Changes in Donor-Derived Cell-Free DNA Upon Treatment
TCMR, ABMR
In patients with histopathological signs of ABMR or TCMR, dd-cfDNA decreased significantly when comparing levels at time of biopsy to levels at 7, 30, and 90 days of follow-up (Longitudinal changes in donor-derived cell-free DNA and estimated glomerular filtration rate. 